The Patent Finder
MR

Medical Research Council

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

4 patents currently held

64 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5 more records may belong here and await a decision; they are not counted.

The next US patent term in the Medical Research Council portfolio ends in Jan 2034, and more of its terms end in 2034 (3) than in any other year. from the record

Of the 64 now held by other companies, 50 name United Kingdom Research and Innovation as their current owner, and 14 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2034
Next term end
4
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Cited by 460 later US patents, top 1% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Ends Apr 2028 · High confidence
Also notable
Cited by 40 later US patents, top 10% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
now held by Bicyclerd Limited
Ends Aug 2030 · High confidence
Also notable
Cited by 25 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030. A terminal disclaimer caps this term to an earlier patent's.
now held by Bicyclerd Limited
Ends Feb 2030 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

  • 1 term has ended since Aug 24, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,954,198Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
In force
 · Medium confidence
In forceMedium confidence
US 10,208,100ANGIOPOIETIN-2 Specific TIE2 Receptor
In force
 · High confidence
In forceHigh confidence
US 10,201,499Nanoparticle Formulation
In force
 · High confidence
In forceHigh confidence
US 12,203,092Self-Inactivating Rabies Virus Vector Encoding a Nucleoprotein and Degron
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 64 patents in force now held by others · 117 patents ended · 1 application pending · 198 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
26 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
18 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited